Counterfeit medicines: A global threat heightened by COVID-19
All the news from Servier Group
Oril Industrie, Servier’s center of excellence in chemistry for the past 60 years!
Servier completes the acquisition of Symphogen
Clinical Trials: Servier adapts to ensure continuity
Servier is more committed than ever in the fight against hypertension!
Phase 1 Results for ALLO-501 in Non-Hodgkin Lymphoma to be Presented at ASCO
Covid-19: Mécénat Servier sets up remote skills-based sponsorship missions
Golden Ticket 2020 awarded to Rgenta Therapeutics, a biotech specializing in diseases considered incurable
COVID-19: The “Health Innovation Coalition – Health Crisis” selects a new projects and the lengthens its call for projects until May 7th.